DEC 06, 2021 5:30 PM PST

Sino Biological Launched Omicron Variant Research Reagents

SPONSORED BY: Sino Biological

Sino Biological Newly Launched A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529)

Beijing, China, December 6th, 2021 – Sino Biological, Inc. (https://www.sinobiological.com, SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the Spike protein.

Sino Biological’s new Omicron product line includes recombinant Omicron Spike proteins (RBD, S1, and S-ECD trimer), monoclonal antibodies recognizing the Omicron Spike protein, and the Omicron pseudovirus assay CRO service. These reagents are critical and urgently needed research tools for scientists and researchers worldwide to understand the impact of the new Omicron mutations on viral transmission as well as therapeutic neutralizing antibody and prophylactic vaccine effectiveness.

"Sino Biological produced the key spike protein reagents within a record 11-days in Jan 2020 and supported thousands of scientists and researchers in over 70 countries worldwide for their COVID-19 research which led to close to 1000 publications to date" Sino Biological CEO Dr. Jie Zhang stated, "With the state-of-the-art platform technology and expertise accumulated over a decade, in a race against time and the pandemic, we are very pleased to be able to produce the Omicron RBD protein in a new record of 6 days, spike binding antibody in 8 days, the spike-S1, S-ECD trimer proteins and pseudovirus in 10 days. We’ll continue to monitor new mutations, and make sure we make research tools available to scientists as quickly as we possibly can."

Sino Biological produces a comprehensive list of research reagents to support the global fight against the COVID-19 pandemic with over 400 protein and antibody reagent products. Sino Biological’s protein and antibody products have also been used to manufacture COVID diagnostic tests.

About Sino Biological

Sino Biological is an international biological reagent supplier and service provider. The company specializes in recombinant antigen production and antibody development. The company’s ever-growing portfolio of products includes over 6,000 recombinant proteins, 13,000 antibodies, ELISA assay kits, expression clones, cell culture media, and other molecular biology tools. The company also offers a variety of customized services, mainly focusing on recombinant production of antigens and antibodies. Sino Biological is dedicated to virology and infectious disease research. Its newly launched ProVirTM collection is the world’s largest viral antigen bank, carrying over 1,000 viral products from 350 strains of viruses.

Forward-Looking Statements

Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, over which Biological has no control. Sino Biological assumes no obligation to update these forward-looking statements and do not intend to do so. More information about these factors is contained in Sino Biological's filings with the Shenzhen Stock Exchange.

 

Contacts:

Sino Biological, Inc.
ir@sinobiological.cn

www.sinobiological.com

About the Sponsor
  • Sino Biological is an internationally-recognized reagent supplier and contract research organization. As a global leader in recombinant technology, it specializes in recombinant protein production and antibody development. All of Sino Biological’s products are independently developed and produced, including 6,000+ recombinant proteins and 13,000+ antibodies. The company has developed the world’s largest recombinant viral antigen bank, ProVir™.
You May Also Like
OCT 27, 2021
Neuroscience
Frankenworld: Should We Be Afraid of Playing God or Failing To Love Our Monsters?
OCT 27, 2021
Frankenworld: Should We Be Afraid of Playing God or Failing To Love Our Monsters?
Lawyer Henry T. Greely analyzes the relevance of Mary Shelley's classic, "Frankenstein," in light of today's bioscience
NOV 04, 2021
Microbiology
Investigating the Gut Virome
NOV 04, 2021
Investigating the Gut Virome
The gut microbiome is a critical part of human health. Research has shown that many types of bacteria may reside there. ...
DEC 09, 2021
Microbiology
Needle in the haystack: How to remove human background when you want to detect microorganisms
DEC 09, 2021
Needle in the haystack: How to remove human background when you want to detect microorganisms
In clinical practice, most patients with severe infections or history of repeated hospitalizations are often referred to ...
DEC 05, 2021
Microbiology
Researchers Find a Lyme Disease Diagnostic & Treatment Target
DEC 05, 2021
Researchers Find a Lyme Disease Diagnostic & Treatment Target
Ticks that carry Lyme disease can be found in more and more places. If a tick is infected with the bacterium that causes ...
DEC 15, 2021
Microbiology
A Genetic Modification Alters Bacterial Behavior to Produce Artistic Swirls
DEC 15, 2021
A Genetic Modification Alters Bacterial Behavior to Produce Artistic Swirls
Researchers engineered a genetic circuit to make pathogenic bacteria called Myxococcus xanthus move in swirled patterns.
DEC 22, 2021
Microbiology
Some Gut Bacteria Produce Toxic Chemicals That Can Damage the Brain
DEC 22, 2021
Some Gut Bacteria Produce Toxic Chemicals That Can Damage the Brain
Gut bacteria perform some essential functions. They help us digest certain foods and absorb nutrients. The community of ...
Loading Comments...